Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Ekologia - Ecology Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudba 2025Webshop Cart
Bratislava Medical Journal Vol.115, No.4, p.233-237, 2014 |
||
Title: A meta-analysis of pemetrexed-based doublet compared with pemetrexed alone for the second-line treatment of advanced non-small-cell lung cancer | ||
Author: C. T. Sun, X. Xu, W. Sheng, X. W. Wang, S. L. Wen, J. Q. Han | ||
Abstract: Purpose: This meta-analysis investigated pemetrexed-based doublet compared with pemetrexed alone as second-line therapy for patients with advanced non-small cell lung cancer. Meta-analysis demonstrated that pemetrexed-based doublet arm significantly improved the overall response rate (OR=2.70, 95% CI: 1.76–4.15, p=0.000), compared with docetaxel alone group, while there were no significant differences in overall survival (HR=0.88, 95% CI: 0.74–1.04, p=0.132), progression-free survival (HR=0.91, 95% CI: 0.73–1.15, p=0.443), and 1-year survival rate (OR=1.43, 95% CI: 0.85–2.40, p=0.178) between the two arms. However, there were more frequencies of grade 3–4 leucopenia (OR=2.86, 95% CI: 1.32–6.20, p=0.008), neutropenia (OR=2.69, 95% CI: 1.55–4.68, p=0.000) and thrombocytopenia (OR=6.92, 95% CI: 2.51–19.07, p=0.000) in pemetrexed-based doublet group. Grade 3–4 anemia (OR=0.62, 95% CI: 0.33–1.18, p=0.144) and fatigue (OR=1.15, 95% CI: 0.73–1.79, p=0.550) had equivalent incidences in the two groups.
|
||
Keywords: non-small-cell lung cancer, docetaxel, second-line therapy, meta-analysis. | ||
Year: 2014, Volume: 115, Issue: 4 | Page From: 233, Page To: 237 | |
doi:10.4149/BLL_2014_048 |
||
|
![]() |
|